Vimarsana
Biggest News Aggregation in the World

Page 8 - Ann Falsey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ann Falsey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ann Falsey Today - Breaking & Trending Today

AstraZeneca's vaccine found to be 79% effective, with no safety issues, in U.S. trial - Vimarsana News

AstraZeneca's vaccine found to be 79% effective, with no safety issues, in U.S. trial

AstraZeneca's vaccine found to be 79% effective, with no safety issues, in U.S. trial Henry Chu © Provided by The LA Times A nurse prepares a dose of the AstraZeneca COVID-19 vaccine in Lyon, France. (Associated Press) AstraZeneca's vaccine was 79% effective at preventing any COVID-19 symptoms and 100% at preventing severe ones, and had no safety issues with blood clots in large-scale U.S. trials, the company said Monday. The results of the trials involving 32,449 people pave the way for AstraZeneca to apply for emergency-use authorization in the United States. The vaccine ...

Source: msn.com
Coronavirus: AstraZeneca hails U.S. trials but poll shows European worries - Vimarsana News

Coronavirus: AstraZeneca hails U.S. trials but poll shows European worries

  WASHINGTON -- Pharmaceutical giant AstraZeneca said Monday that US trials showed its COVID-19 vaccine was 100 percent effective in preventing severe disease, even as a poll showed trust in the jab had plunged in many European countries. The AstraZeneca shot is cheaper and easier to store than many of its rivals, but its use was thrown into chaos when several nations in Europe and other parts of the world last week suspended their rollouts because of isolated cases of blood clots. Vaccination drives are seen as crucial to overcoming the pandemic that has killed more than 2.7 million peo...

Source: ctvnews.ca
Connections: Understanding COVID-19 vaccine science and distribution - Vimarsana News

Connections: Understanding COVID-19 vaccine science and distribution

Understanding COVID-19 vaccine science and distribution New York is in its second week of administering COVID-19 vaccines to people in Phase 1 of the process. Do you have questions about the vaccines or what you need to know when it’s your turn? This hour, we're joined by two local experts who have been at the forefront of the national and local coronavirus response. They answer your questions about vaccine science, distribution, timelines, and more. Our guests: Dr. Nancy Bennett, director of the Center for Community Health and Prevention, and co-director of the Clinical and Translational S...

Coming up on Connections: Tuesday, December 22 - Vimarsana News

Coming up on Connections: Tuesday, December 22

First hour: Understanding COVID-19 vaccine science and distribution Second hour: Exploring the region during the pandemic winter New York is in its second week of administering COVID-19 vaccines to people in Phase 1 of the process. Do you have questions about the vaccines or what you need to know when it’s your turn? This hour, we're joined by two local experts who have been at the forefront of the national and local coronavirus response. They answer your questions about vaccine science, distribution, timelines, and more. Our guests: Dr. Nancy Bennett, director of the Center for Community H...